News
Novartis has received European Commission approval for its acute gouty arthritis medicine
Patient organisation, PatientsLikeMe, has won a grant to create an open-participation research platform to help researchers develop better health outcome measures. The Robert Wood Johnson Foundation has awarded PatientsLikeMe with a US $1.9 million grant so it can create the world’s first…
Today is Rare Disease Day and many companies, both pharma and rare disease organisations, have announced their support for this awareness initiative. Today marks the sixth international Rare Disease Day, led by EURORDIS, to raise awareness for patients with rare…
Bayer’s Stivarga has had its approval expanded through the FDA’s priority review program to treat rare disease patients with GIST. The US FDA approval of Bayer’s Stivarga has been expanded so as to treat rare disease patients with advanced…
UCB reports a 7% revenue growth for the full-year 2012, largely due to its core medicines in the areas of the central nervous system and immunology. UCB has announced that its core medicines were key to the company’s growth in 2012. Revenue increased by…
Phase 3 clinical trial data shows that Boehringer Ingelheim’s asthma drug significantly improved lung function over a 24-week period. Boehringer Ingelheim has announced positive phase 3 clinical trial data for its asthma drug, tiotropium Respimat. The…
Dynavax’s adult hepatitis B vaccine has been rejected for approval by the US FDA, who has requested additional data regarding the broad age indication of the vaccination. The US FDA has rejected Dynaxax Technologies’ Biologic License Application for its investigational adult…
